Journey Medical Corporation to Participate in September 2025 Investor Conferences

Rhea-AI Summary

Journey Medical Corporation (NASDAQ:DERM), a commercial-stage pharmaceutical company focused on marketing FDA-approved dermatological treatments, has announced its participation in two upcoming investor conferences in September 2025.

CEO Claude Maraoui will attend the H.C. Wainwright 27th Annual Global Investment Conference on September 8, participating in a fireside chat and one-on-one meetings. Additionally, the company will participate in the Lake Street Capital Markets 9th Annual Best Ideas Growth Conference on September 11, featuring one-on-one meetings with investors.

SCOTTSDALE, Ariz., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company primarily focused on selling and marketing U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that Claude Maraoui, Co-Founder, President and Chief Executive Officer, will participate in two September 2025 investor conferences.

Details of the events are as follows:

H.C. Wainwright 27th Annual Global Investment Conference
Date and Time: Monday, September 8, 2025, at 1:30 p.m. ET
Location: New York City
Format: Fireside Chat and 1x1 Meetings

Lake Street Capital Markets 9th Annual Best Ideas Growth (BIG9) Conference
Date: Thursday, September 11, 2025
Location: New York City
Format: 1x1 Meetings

About Journey Medical Corporation
Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”) is a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions through its efficient sales and marketing model. The Company currently markets eight branded FDA-approved prescription drugs that help treat and heal common skin conditions. The Journey Medical team comprises industry experts with extensive experience in developing and commercializing some of dermatology’s most successful prescription brands. Journey Medical is located in Scottsdale, Arizona and was founded by Fortress Biotech, Inc. (Nasdaq: FBIO). Journey Medical’s common stock is registered under the Securities Exchange Act of 1934, as amended, and it files periodic reports with the U.S. Securities and Exchange Commission (“SEC”). For additional information about Journey Medical, visit www.journeymedicalcorp.com.

Company Contact:
Jaclyn Jaffe
(781) 652-4500
ir@jmcderm.com

Media Relations Contact:
Tony Plohoros
6 Degrees
(908) 591-2839
tplohoros@6degreespr.com    

FAQ

When is Journey Medical's (DERM) presentation at the H.C. Wainwright Conference 2025?

Journey Medical will present at the H.C. Wainwright Conference on Monday, September 8, 2025, at 1:30 p.m. ET in New York City.

Who will represent Journey Medical (DERM) at the September 2025 investor conferences?

Claude Maraoui, the Co-Founder, President and Chief Executive Officer of Journey Medical, will represent the company at both conferences.

What type of meetings will Journey Medical (DERM) participate in at the Lake Street Conference?

Journey Medical will participate in one-on-one meetings at the Lake Street Capital Markets Best Ideas Growth Conference on September 11, 2025.

Where are the Journey Medical (DERM) investor conferences being held in September 2025?

Both conferences will be held in New York City.